|
"yen c j"的相关文件
显示项目 386-395 / 471 (共48页)
<< < 34 35 36 37 38 39 40 41 42 43 > >>
每页显示[10|25|50]项目
| 國立成功大學 |
2018 |
The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma
|
Hsiao, J.-R.;Chang, Chang C.-C.;Lee, W.-T.;Huang, C.-C.;Ou, C.-Y.;Tsai, S.-T.;Chen, K.-C.;Huang, J.-S.;Wong, T.-Y.;Lai, Y.-H.;Wu, Y.-H.;Hsueh, W.-T.;Wu, S.-Y.;Yen, C.-J.;Chang, J.-Y.;Lin, C.-L.;Weng, Y.-L.;Yang, H.-C.;Chen, Y.-S.;Chang, J.S. |
| 國立成功大學 |
2018 |
Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection
|
Yen, C.-J.;Ai, Y.-L.;Tsai, H.-W.;Chan, S.-H.;Yen, C.-S.;Cheng, K.-H.;Lee, Y.-P.;Kao, C.-W.;Wang, Y.-C.;Chen, Y.-L.;Lin, C.-H.;Liu, T.;Tsai, H.-P.;Wang, J.-R.;Su, I.-J.;Huang, W. |
| 國立成功大學 |
2018 |
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
|
Abou-Alfa, G.K.;Qin, S.;Ryoo, B.-Y.;Lu, S.-N.;Yen, C.-J.;Feng, Y.-H.;Lim, H.Y.;Izzo, F.;Colombo, M.;Sarker, D.;Bolondi, L.;Vaccaro, G.;Harris, W.P.;Chen, Z.;Hubner, R.A.;Meyer, T.;Sun, W.;Harding, J.J.;Hollywood, E.M.;Ma, J.;Wan, P.J.;Ly, M.;Bomalaski, J.;Johnston, A.;Lin, C.-C.;Chao, Y.;Chen, L.-T. |
| 國立成功大學 |
2018 |
Ramucirumab safety in East Asian patients: A meta-analysis of six global, randomized, double-blind, placebo-controlled, phase III clinical trials
|
Yen, C.-J.;Muro, K.;Kim, T.-W.;Kudo, M.;Shih, J.-Y.;Lee, K.-W.;Chao, Y.;Kim, S.-W.;Yamazaki, K.;Sohn, J.;Cheng, R.;Zhang, Y.;Binder, P.;Mi, G.;Orlando, M.;Chung, H.C. |
| 國立成功大學 |
2018 |
Phase II studies with refametinib or refametinib plus sorafenib in patients with RAS-mutated hepatocellular Carcinoma
|
Lim, H.Y.;Merle, P.;Weiss, K.H.;Yau, T.;Ross, P.;Mazzaferro, V.;Blanc, J.-F.;Ma, Y.T.;Yen, C.J.;Kocsis, J.;Choo, S.P.;Sukeepaisarnjaroen, W.;Gerolami, R.;Dufour, J.-F.;Gane, E.J.;Ryoo, B.-Y.;Peck-Radosavljevic, M.;Dao, T.;Yeo, W.;Lamlertthon, W.;Thongsawat, S.;Teufel, M.;Roth, K.;Reis, D.;Childs, B.H.;Krissel, H.;Llovet, J.M. |
| 國立成功大學 |
2018 |
Exposure–response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer
|
Kim, T.Y.;Yen, C.-J.;Al-Batran, S.-E.;Ferry, D.;Gao, L.;Hsu, Y.;Cheng, R.;Orlando, M.;Ohtsu, A. |
| 國立成功大學 |
2018 |
Hepatocellular carcinoma–related cyclin D1 is selectively regulated by autophagy degradation system
|
Wu, S.-Y.;Lan, S.-H.;Wu, S.-R.;Chiu, Y.-C.;Lin, X.-Z.;Su, I.-J.;Tsai, Tsai T.-F.;Yen, C.-J.;Lu, T.-H.;Liang, F.-W.;Li, C.-Y.;Su, H.-J.;Su, C.-L.;Liu, H.-S. |
| 國立成功大學 |
2018 |
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study
|
Chau, I.;Park, J.O.;Ryoo, B.-Y.;Yen, C.-J.;Poon, R.;Pastorelli, D.;Blanc, J.-F.;Kudo, M.;Pfiffer, T.;Hatano, E.;Chung, H.C.;Kopeckova, Kopeckova K.;Phelip, J.-M.;Brandi, G.;Ohkawa, S.;Li, C.-P.;Okusaka, T.;Hsu, Y.;Abada, P.B.;Zhu, A.X. |
| 國立成功大學 |
2018 |
A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma
|
Yen, C.-J.;Kim, T.-Y.;Feng, Y.-H.;Chao, Y.;Lin, D.-Y.;Ryoo, B.-Y.;Huang, D.C.-L.;Schnell, D.;Hocke, J.;Loemb�, A.-B.;Cheng, A.-L. |
| 國立成功大學 |
2017-12-01 |
Hydrogen gas protects IP3Rs by reducing disulfide bridges in human keratinocytes under oxidative stress
|
Wu, C.-Y.;Hsu, W.-L.;Tsai, M.-H.;Liang, J.-L.;Lu, J.-H.;Yen, C.-J.;Yu, H.-S.;Noda, M.;Lu, C.-Y.;Chen, C.-H.;Yan, S.-J.;Yoshioka, T.; 顏賢章 |
显示项目 386-395 / 471 (共48页)
<< < 34 35 36 37 38 39 40 41 42 43 > >>
每页显示[10|25|50]项目
|
